Melexis N.V.
MLXSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $933 | $964 | $836 | $644 |
| % Growth | -3.3% | 15.3% | 29.9% | – |
| Cost of Goods Sold | $531 | $524 | $461 | $370 |
| Gross Profit | $401 | $440 | $375 | $274 |
| % Margin | 43% | 45.7% | 44.8% | 42.5% |
| R&D Expenses | $110 | $107 | $90 | $78 |
| G&A Expenses | $51 | $51 | $41 | $16 |
| SG&A Expenses | $71 | $72 | $58 | $19 |
| Sales & Mktg Exp. | $20 | $22 | $17 | $3 |
| Other Operating Expenses | $0 | -$1 | -$1 | -$1 |
| Operating Expenses | $181 | $179 | $148 | $125 |
| Operating Income | $220 | $261 | $227 | $148 |
| % Margin | 23.6% | 27.1% | 27.1% | 23.1% |
| Other Income/Exp. Net | -$15 | -$8 | $12 | $6 |
| Pre-Tax Income | $205 | $253 | $238 | $154 |
| Tax Expense | $34 | $44 | $41 | $23 |
| Net Income | $171 | $209 | $197 | $131 |
| % Margin | 18.4% | 21.7% | 23.6% | 20.4% |
| EPS | 4.24 | 5.18 | 4.88 | 3.25 |
| % Growth | -18.1% | 6.1% | 50.2% | – |
| EPS Diluted | 4.24 | 5.18 | 4.88 | 3.25 |
| Weighted Avg Shares Out | 40 | 40 | 40 | 40 |
| Weighted Avg Shares Out Dil | 40 | 40 | 40 | 40 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $11 | $6 | $1 | $1 |
| Depreciation & Amortization | $46 | $43 | $45 | $44 |
| EBITDA | $266 | $305 | $270 | $193 |
| % Margin | 28.5% | 31.6% | 32.3% | 29.9% |